Leveraging antimicrobial stewardship into improving rates of carbapenem-resistant Enterobacteriaceae
- PMID: 27187821
- PMCID: PMC5477703
- DOI: 10.1080/21505594.2016.1188234
Leveraging antimicrobial stewardship into improving rates of carbapenem-resistant Enterobacteriaceae
Abstract
Carbapenem-resistant Enterobacteriaceae (CRE) are among the most critical threats facing our healthcare system and account for significant patient mortality. There is considerable interest in the development of new treatment strategies. However, less attention has been paid to reducing CRE infection rates. Antibiotic stewardship programs can be uniquely empowered to reduce widespread pathogen resistance and by extension, optimize patient care and lower healthcare costs.
Keywords: CRE; KPC; Klebsiella pneumnoniae carbapenemase; antibiotic stewardship.
Similar articles
-
Multicenter Study of the Risk Factors for Colonization or Infection with Carbapenem-Resistant Enterobacteriaceae in Children.Antimicrob Agents Chemother. 2017 Nov 22;61(12):e01440-17. doi: 10.1128/AAC.01440-17. Print 2017 Dec. Antimicrob Agents Chemother. 2017. PMID: 28971864 Free PMC article.
-
The Impact of a Carbapenem-Resistant Enterobacteriaceae Outbreak on Facilitating Development of a National Infrastructure for Infection Control in Israel.Clin Infect Dis. 2017 Nov 29;65(12):2144-2149. doi: 10.1093/cid/cix615. Clin Infect Dis. 2017. PMID: 29020228
-
Infection control implications of heterogeneous resistance mechanisms in carbapenem-resistant Enterobacteriaceae (CRE).Expert Rev Anti Infect Ther. 2016;14(1):95-108. doi: 10.1586/14787210.2016.1106940. Epub 2015 Nov 4. Expert Rev Anti Infect Ther. 2016. PMID: 26535959 Review.
-
[Clinical characteristics of carbapenem-resistant Enterobacteriaceae infection in pediatric liver transplantation recipients].Zhonghua Er Ke Za Zhi. 2020 Aug 2;58(8):640-645. doi: 10.3760/cma.j.cn112140-20200316-00239. Zhonghua Er Ke Za Zhi. 2020. PMID: 32842384 Chinese.
-
Clinical and laboratory considerations for the rapid detection of carbapenem-resistant Enterobacteriaceae.Virulence. 2017 May 19;8(4):427-439. doi: 10.1080/21505594.2016.1185577. Epub 2016 May 11. Virulence. 2017. PMID: 27168451 Free PMC article. Review.
Cited by
-
Comparison of the inoculum effect of in vitro antibacterial activity of Imipenem/relebactam and Ceftazidime/avibactam against ESBL-, KPC- and AmpC-producing Escherichia coli and Klebsiella pneumoniae.Ann Clin Microbiol Antimicrob. 2023 Dec 10;22(1):107. doi: 10.1186/s12941-023-00660-5. Ann Clin Microbiol Antimicrob. 2023. PMID: 38072972 Free PMC article.
-
The impact of hospital-specific guidelines on carbapenem use and patient outcomes in a setting for high endemicity with multidrug-resistant gram-negative bacilli.Antimicrob Steward Healthc Epidemiol. 2024 Sep 25;4(1):e146. doi: 10.1017/ash.2024.415. eCollection 2024. Antimicrob Steward Healthc Epidemiol. 2024. PMID: 39346671 Free PMC article.
-
Effects of Regulation on Carbapenem Prescription in a Large Teaching Hospital in China: An Interrupted Time Series Analysis, 2016-2018.Infect Drug Resist. 2021 Aug 11;14:3099-3108. doi: 10.2147/IDR.S322938. eCollection 2021. Infect Drug Resist. 2021. PMID: 34408453 Free PMC article.
-
Carbapenem-resistant Enterobacteriaceae: What we know and what we need to know.Virulence. 2017 May 19;8(4):379-382. doi: 10.1080/21505594.2017.1306621. Epub 2017 Apr 12. Virulence. 2017. PMID: 28402724 Free PMC article. No abstract available.
-
Applying Diagnostic Stewardship to Proactively Optimize the Management of Urinary Tract Infections.Antibiotics (Basel). 2022 Feb 24;11(3):308. doi: 10.3390/antibiotics11030308. Antibiotics (Basel). 2022. PMID: 35326771 Free PMC article. Review.
References
-
- Pollack LA, Srinivasan A. Core elements of hospital antibiotic stewardship programs from the Centers for Disease Control and Prevention. Clin Infect Dis 2014; 59 Suppl 3:S97-100; PMID:25261548; https://doi.org/10.1093/cid/ciu542 - DOI - PMC - PubMed
-
- Camins BC, King MD, Wells JB, Googe HL, Patel M, Kourbatova EV, Blumberg HM. Impact of an antimicrobial utilization program on antimicrobial use at a large teaching hospital: a randomized controlled trial. Infect Control Hosp Epidemiol 2009; 30:931-8; PMID:19712032; https://doi.org/10.1086/605924 - DOI - PMC - PubMed
-
- Report to the President on Combating Antibiotic Resistance Executive Office of the President: President's Council of Advisors on Science and Technology, 2014
-
- Barlam TF, Cosgrove SE, Abbo LM, MacDougall C, Schuetz AN, Septimus EJ, Srinivasan A, Dellit TH, Falck-Ytter YT, Fishman NO, et al. . Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis 2016; 62:e51-77; PMID:27080992; https://doi.org/10.1093/cid/ciw118 - DOI - PMC - PubMed
-
- Nowak MA, Nelson RE, Breidenbach JL, Thompson PA, Carson PJ. Clinical and economic outcomes of a prospective antimicrobial stewardship program. Am J Health Syst Pharm 2012; 69:1500-8; PMID:22899745; https://doi.org/10.2146/ajhp110603 - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical